128 related articles for article (PubMed ID: 6547008)
21. [Cutaneous necrosis at the initiation of antivitamin K treatment disclosing hereditary protein C deficiency].
Piffoux M; Tcherakian F; Tcherakian S; Horellou MH
Rev Pneumol Clin; 1990; 46(3):125-7. PubMed ID: 2237146
[TBL] [Abstract][Full Text] [Related]
22. Clinical studies of protein C.
Griffin JH
Semin Thromb Hemost; 1984 Apr; 10(2):162-6. PubMed ID: 6377499
[TBL] [Abstract][Full Text] [Related]
23. [A sporadic case of protein C deficiency].
Ishimaru F; Hayashi H; Ueki K; Fujita T; Tsurumi N; Tsuda T; Kimura I
Rinsho Ketsueki; 1990 Nov; 31(11):1856-61. PubMed ID: 2287072
[TBL] [Abstract][Full Text] [Related]
24. [Familial deficiency of protein S associated with thrombophilia].
Velasco F; Rojas R; Torres A
Med Clin (Barc); 1989 Apr; 92(13):484-7. PubMed ID: 2526275
[TBL] [Abstract][Full Text] [Related]
25. Dietary induced subclinical vitamin K deficiency in normal human subjects.
Ferland G; Sadowski JA; O'Brien ME
J Clin Invest; 1993 Apr; 91(4):1761-8. PubMed ID: 8473516
[TBL] [Abstract][Full Text] [Related]
26. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
27. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
28. Severe protein C deficiency in congenital thrombotic disease--description of an immunoenzymological assay for protein C determination.
Soria J; Soria C; Samama M; Nicolas G; Kisiel W
Thromb Haemost; 1985 Jun; 53(3):293-6. PubMed ID: 3901386
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
30. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN
Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163
[TBL] [Abstract][Full Text] [Related]
31. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
32. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
Tripodi A; Primignani M; Chantarangkul V; Dell'Era A; Clerici M; de Franchis R; Colombo M; Mannucci PM
Gastroenterology; 2009 Dec; 137(6):2105-11. PubMed ID: 19706293
[TBL] [Abstract][Full Text] [Related]
33. Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy.
Viganò S; Mannucci PM; Solinas S; Bottasso B; Mariani G
Br J Haematol; 1984 Jun; 57(2):213-20. PubMed ID: 6547348
[TBL] [Abstract][Full Text] [Related]
34. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
35. Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism.
Kovacs MJ; Kovacs J; Anderson J; Rodger MA; Mackinnon K; Wells PS
Clin Lab Haematol; 2006 Feb; 28(1):9-13. PubMed ID: 16430453
[TBL] [Abstract][Full Text] [Related]
36. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
[TBL] [Abstract][Full Text] [Related]
37. [Studies on low protein C-expression in severe sepsis].
Manekeller S; Hertfelder HJ; von Spiegel T; Hering R; Putensen C; Schroeder S
Zentralbl Chir; 2005 Aug; 130(4):362-7. PubMed ID: 16103962
[TBL] [Abstract][Full Text] [Related]
38. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
39. Hereditary protein C-deficiency: laboratory values in transmitters and guidelines for the diagnostic procedure. Report on a study of the SSC Subcommittee on Protein C and Protein S. Protein C Transmitter Study Group.
Pabinger I; Allaart CF; Hermans J; Briët E; Bertina RM
Thromb Haemost; 1992 Oct; 68(4):470-4. PubMed ID: 1448781
[TBL] [Abstract][Full Text] [Related]
40. Multicenter comparison of five functional and two immunological assays for protein C.
Mannucci PM; Boyer C; Tripodi A; Viganò-D'Angelo S; Wolf M; Valsecchi C; D'Angelo A; Meyer D; Larrieu MJ
Thromb Haemost; 1987 Feb; 57(1):44-8. PubMed ID: 3590079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
